Specialty

The administration of nerve block anesthesia in combination with sevoflurane to patients with uterine fibroids undergoing myomectomy may significantly reduce the stress response, maintain hemodynamic stability, and reduce adverse reactions and cognitive impairment. Sevoflurane is a newer inhalation anesthetic with broad market prospects and few side effects. Numerous experiments have shown sevoflurane to have stable...

Difamilast ointment is superior to vehicle in terms of severity index score and overall eczema area in patients with AD, according to a recent trial, which reported only mild to moderate adverse effects of difamilast. Atopic dermatitis (AD) is an inflammatory skin condition that frequently occurs in children. AD has a relapsing-remitting nature and is...

In patients stabilized on tafamidis, SGLT2 inhibitors may be beneficial for improving outcomes of transthyretin amyloid cardiomyopathy (ATTR-CM). Treatment with dapagliflozin was found to be well-tolerated in patients with ATTR-CM. Transthyretin amyloid cardiomyopathy (ATTR-CM) is a heart disease that can be fatal. In recent years, more and more people have been diagnosed and subsequently hospitalized...

Patients with sickle cell anemia (SCA) may be protected from severe disease with malaria. However, severe complications, such as severe drops in hemoglobin, may occur in SCA patients with concomitant low-density malarial infection. Sickle cell anemia (SCA) has historically been linked to high levels of childhood mortality in Africa, with malaria playing a significant role....

L-glutamine is an FDA-approved treatment for sickle cell disease. One study explored the potential benefits and mechanism of action of L-glutamine in sickle cell disease patients. Leukocytosis is common in sickle cell disease (SCD) in the absence of infection and is a predictor for increased risk of stroke, acute chest syndrome, and mortality. Oral L-glutamine...

Supplementation with omega-3 or vitamin D may be useful for preventing and treating pain in patients with SCD. One study assessed the effects of supplementation in conjunction with standard therapy. A common clinical feature present in sickle cell disease (SCD) is pain caused by the distortion of red blood cells and the subsequent blocking of...

Research suggests that minorities are less likely to be prescribed newer diabetes medications than their White counterparts of similar socioeconomic status and diabetes management. As of 2021, the United States Food and Drug Administration (FDA) approved nearly 60 drugs for treating Type 2 Diabetes, and almost 100 additional antidiabetic agents were evaluated in clinical trials1....

Minority underrepresentation in clinical trials can adversely affect patient outcomes in minority populations and further increase racial disparities. Racial disparities in clinical trials adversely affect patient outcomes in minority populations. Although historically, Black populations have been used as unconsenting research participants in studies such as the Tuskegee Syphilis Experiment which began in 1932, or the...

Research shows that Asian, Hispanic, and Black Americans are at increased risk for diabetes at lower weights and younger ages than White Americans. Adult-onset diabetes is one of the most common chronic conditions in adults in the United States. According to the Centers for Disease Control’s (CDC) 2021 statistics, 11.3% of the U.S. population has...